Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2021-09-20
DOI
10.1080/14787210.2021.1982695
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
- (2021) Farzan Solimani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2021) Timotius Ivan Hariyanto et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Parkinson’s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Cynthia Putri et al. PARKINSONISM & RELATED DISORDERS
- Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
- (2021) Timotius I. Hariyanto et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
- (2021) Roman Maslennikov et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies
- (2021) Timotius Ivan Hariyanto et al. REVIEWS IN MEDICAL VIROLOGY
- Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis
- (2021) Timotius Ivan Hariyanto et al. SLEEP MEDICINE
- Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
- (2021) Milo Gatti et al. Pharmaceuticals
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
- (2020) Andrea Picchianti Diamanti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
- (2020) Danielle Peterson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Danielle Peterson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- COVID-19 and comorbidities: a systematic review and meta-analysis
- (2020) Morgan Spencer Gold et al. POSTGRADUATE MEDICINE
- Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
- (2020) Valentina Giudice et al. Frontiers in Pharmacology
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
- (2020) Jose Luis Rodriguez-Garcia et al. RHEUMATOLOGY
- Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
- (2020) Vanessa Castelli et al. Frontiers in Immunology
- Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection
- (2020) Timotius Ivan Hariyanto et al. JOURNAL OF MEDICAL VIROLOGY
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
- (2020) Timotius Ivan Hariyanto et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
- (2020) José Rosas et al. Reumatologia Clinica
- Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
- (2018) Sumit Kunwar et al. CLINICAL RHEUMATOLOGY
- Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
- (2018) Bruce E Sands et al. Journal of Crohns & Colitis
- Perioperative Antibiotics to Prevent Acute Endophthalmitis after Ophthalmic Surgery: A Systematic Review and Meta-Analysis
- (2016) Jinzhu Huang et al. PLoS One
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started